These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31513335)

  • 41. Botulinum toxin type A inhibits M1 macrophage polarization by deactivation of JAK2/STAT1 and IκB/NFκB pathway and contributes to scar alleviation in aseptic skin wound healing.
    Zou YP; Shan XF; Qiu JX; Wang LN; Xiang RL; Cai ZG
    Biomed Pharmacother; 2024 May; 174():116468. PubMed ID: 38518603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized controlled trial of the embrace advanced scar therapy device to reduce incisional scar formation.
    Longaker MT; Rohrich RJ; Greenberg L; Furnas H; Wald R; Bansal V; Seify H; Tran A; Weston J; Korman JM; Chan R; Kaufman D; Dev VR; Mele JA; Januszyk M; Cowley C; McLaughlin P; Beasley B; Gurtner GC
    Plast Reconstr Surg; 2014 Sep; 134(3):536-546. PubMed ID: 24804638
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of botulinum toxin type A for treating hypertrophic scars: A split-scar, double-blind randomized controlled trial.
    Elshahed AR; Elmanzalawy KS; Shehata H; ElSaie ML
    J Cosmet Dermatol; 2020 Sep; 19(9):2252-2258. PubMed ID: 32668499
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improving the Appearance of Surgical Facial Scars With IncobotulinumtoxinA and Microneedling.
    Casabona GR; Giacomo TB
    J Drugs Dermatol; 2020 Jun; 19(6):611-615. PubMed ID: 32574010
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Postoperative incision scars and cosmetic satisfaction of living liver donors.
    Hsu YL; Hsieh CE; Lin PY; Lin SL; Lin KH; Weng LC; Chen YL
    Medicine (Baltimore); 2021 Jun; 100(23):e26187. PubMed ID: 34115002
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Meta-analysis of efficacy of pressure therapy in treating patients with hypertrophic scars].
    Tian LY; Li YL; Wu Y; Zhang Y
    Zhonghua Shao Shang Za Zhi; 2019 Sep; 35(9):668-675. PubMed ID: 31594185
    [No Abstract]   [Full Text] [Related]  

  • 47. Efficacy of Botulinum Toxin Type A for Prevention of Post-Mastectomy Scar in Transmen: A Prospective, Randomized Study.
    Winayanuwattikun W; Vachiramon V; Rattananukrom T; Palakornkitti P; Sitpahul N
    Toxins (Basel); 2023 Oct; 15(11):. PubMed ID: 37999499
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of Botulinum Toxin A in Preventing Recurrence Keloids: Double Blinded Randomized Controlled Trial Study: Intraindividual Subject.
    Pruksapong C; Yingtaweesittikul S; Burusapat C
    J Med Assoc Thai; 2017 Mar; 100(3):280-6. PubMed ID: 29911784
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical trial to evaluate the efficacy of botulinum toxin type A injection for reducing scars in patients with forehead laceration: A double-blinded, randomized controlled study.
    Kim SH; Lee SJ; Lee JW; Jeong HS; Suh IS
    Medicine (Baltimore); 2019 Aug; 98(34):e16952. PubMed ID: 31441893
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early postoperative treatment of thyroidectomy scars using botulinum toxin: a split-scar, double-blind randomized controlled trial.
    Kim YS; Lee HJ; Cho SH; Lee JD; Kim HS
    Wound Repair Regen; 2014; 22(5):605-12. PubMed ID: 24898579
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Concentration-Dependent Inhibition of Hypertrophic Scar Formation by Botulinum Toxin Type A in a Rabbit Ear Model.
    Yang Z; Lv Y; Yang Z; Cao L; Cao D
    Aesthetic Plast Surg; 2022 Dec; 46(6):3072-3079. PubMed ID: 35864206
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Botulinum toxin type A for the treatment and prevention of hypertrophic scars and keloids: Updated review.
    Kasyanju Carrero LM; Ma WW; Liu HF; Yin XF; Zhou BR
    J Cosmet Dermatol; 2019 Feb; 18(1):10-15. PubMed ID: 30548742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of Botulinum Toxin in the Treatment of Facial and Cervical Hypertrophic Scar: A Meta-Analysis.
    Yin D; Xi M; Jiang L; Du M; Qi J
    Altern Ther Health Med; 2024 Mar; ():. PubMed ID: 38518155
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Scar Assessment After Breast Augmentation Surgery with Axillary Incision versus Inframammary Fold Incision: Long-Term Follow-Up in Chinese Patients.
    Sun J; Mu D; Liu C; Ji K; Chen L; Liu W; Luan J
    Aesthetic Plast Surg; 2016 Oct; 40(5):699-706. PubMed ID: 27484988
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of intralesional injection of botulinum toxin type A injection for hypertrophic scars.
    Elhefnawy AM
    Indian J Dermatol Venereol Leprol; 2016; 82(3):279-83. PubMed ID: 27088929
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and Safety of Pressure Therapy Alone and in Combination with Silicone in Prevention of Hypertrophic Scars: A Systematic Review with Meta-analysis of Randomized Controlled Trials.
    Zhang P; Wu Q; Ding H; Bai R; Meng F; Xu X; Chen M
    Aesthetic Plast Surg; 2023 Oct; 47(5):2159-2174. PubMed ID: 37648929
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and Safety of Single Botulinum Toxin Type A (Botox®) Injection for Relief of Upper Trapezius Myofascial Trigger Point: A Randomized, Double-Blind, Placebo-Controlled Study.
    Kwanchuay P; Petchnumsin T; Yiemsiri P; Pasuk N; Srikanok W; Hathaiareerug C
    J Med Assoc Thai; 2015 Dec; 98(12):1231-6. PubMed ID: 27004309
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Battling Neuropathic Scar Pain With Botulinum Toxin.
    Schuler A; Veenstra J; Ozog D
    J Drugs Dermatol; 2019 Sep; 18(9):937-938. PubMed ID: 31524351
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of botulinum toxin type A for treatment of Frey's syndrome: evidence from 22 published articles.
    Xie S; Wang K; Xu T; Guo XS; Shan XF; Cai ZG
    Cancer Med; 2015 Nov; 4(11):1639-50. PubMed ID: 26310612
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke.
    Bakheit AM; Pittock S; Moore AP; Wurker M; Otto S; Erbguth F; Coxon L
    Eur J Neurol; 2001 Nov; 8(6):559-65. PubMed ID: 11784339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.